GALNT6, overexpressed in ccRCC, drives Tn antigen synthesis and promotes tumor proliferation through aberrant O-glycosylation, underscoring its potential as a therapeutic target [222]. Here, GALNT6 is linked to nonpapillary renal cell carcinoma.